DYLAN NEAL: Open Payments
NPI 1457024606 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 6 companies in 2025. Trend: 2023 $417 · 2024 $18 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $145 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $61 |
| LEO Pharma Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $18 |
| Biofrontera Inc. | 1 | $15 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, ANZUPGO, TALTZ.
Industry payments across CA — which companies pay providers there.
